| PERIOD ENDING | 29-Jun-08 | 30-Mar-08 | 30-Dec-07 | 30-Sep-07 | | Total Revenue | 741,905 | 747,855 | 865,755 | 754,359 | | Cost of Revenue | 324,399 | 340,564 | 338,187 | 331,962 | | | Gross Profit | 417,506 | 407,291 | 527,568 | 422,397 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 344,609 | 340,854 | 368,368 | 342,503 | | Non Recurring |
-
| 18,291 | 11,000 |
-
| | Others | 32,642 | 41,931 | 46,690 | 51,789 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 40,255 | 6,215 | 101,510 | 28,105 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,263 | (1,793) | (7,236) | 8,004 | | Earnings Before Interest And Taxes | 50,518 | 4,422 | 94,274 | 33,517 | | Interest Expense | 12,202 | 11,745 | 14,304 | 10,470 | | Income Before Tax | 38,316 | (7,323) | 79,970 | 23,047 | | Income Tax Expense | 17,251 | (7,692) | 27,396 | 8,991 | | Minority Interest | (213) | (104) | 68 | 54 | | | | Net Income From Continuing Ops | 20,852 | 265 | 52,642 | 14,110 | | | Non-recurring Events | | Discontinued Operations | 289 | (600) | 353 | (671) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,141 | (335) | 52,995 | 13,439 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,141 | ($335) | $52,995 | $13,439 |
|
1.49% Nasdaq 
0.27%
Income Statement
